Q1: 2026-04-29 Earnings Summary
EPS of $3.57 beats by $0.68
|
Revenue of
$2.48B
(1.93% Y/Y)
beats by $231.72M
Biogen Inc. (BIIB) Q1 2026 Earnings Call April 29, 2026 8:00 AM EDT
Company Participants
Tim Power - Head of Investor Relations
Christopher Viehbacher - President, CEO & Director
Priya Singhal - Executive VP & Head of Development
Robin Kramer - Executive VP & CFO
Alisha Alaimo - President & Head of North America
Conference Call Participants
Brian Abrahams - RBC Capital Markets, Research Division
Lin Tsai - Jefferies LLC, Research Division
Geoffrey Meacham - Citigroup Inc., Research Division
Michael Yee - UBS Investment Bank, Research Division
Salveen Richter - Goldman Sachs Group, Inc., Research Division
David Amsellem - Piper Sandler & Co., Research Division
Paul Matteis - Stifel, Nicolaus & Company, Incorporated, Research Division
Mohit Bansal - Wells Fargo Securities, LLC, Research Division
Evan Seigerman - BMO Capital Markets Equity Research
Alexandria Hammond - Wolfe Research, LLC
Terence Flynn - Morgan Stanley, Research Division
Jay Olson - Oppenheimer & Co. Inc., Research Division
Presentation
Operator
Good morning. My name is Cynthia, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen First Quarter 2026 Earnings Call and Business Update. [Operator Instructions] Today's conference is being recorded. Thank you.
I would now like to turn the conference over to Mr. Tim Power, Head of Investor Relations. Mr. Power, you may begin your conference.
Tim Power
Head of Investor Relations
Well, thank you, and good morning, and welcome to Biogen's First Quarter 2026 Earnings Call. During this call, we will make forward-looking statements, which involve risks and uncertainties that may cause actual results to differ materially from our forward-looking statements. We provide a comprehensive list of risk factors in our SEC filings, which we encourage you to review. Our earnings release and other documents related to our results as well as reconciliations between GAAP and non-GAAP results discussed on this call can be found in the Investors section of biogen.com. We've also posted the
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。